These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 20403046)

  • 1. Epigenetic methylation and expression of caspase 8 and survivin in hepatocellular carcinoma.
    Cho S; Lee JH; Cho SB; Yoon KW; Park SY; Lee WS; Park CH; Joo YE; Kim HS; Choi SK; Rew JS
    Pathol Int; 2010 Mar; 60(3):203-11. PubMed ID: 20403046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
    Ikeguchi M; Hirooka Y; Kaibara N
    Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of survivin mRNA associates with apoptosis, proliferation and histologically aggressive features in hepatocellular carcinoma.
    Morinaga S; Nakamura Y; Ishiwa N; Yoshikawa T; Noguchi Y; Yamamoto Y; Rino Y; Imada T; Takanashi Y; Akaike M; Sugimasa Y; Takemiya S
    Oncol Rep; 2004 Dec; 12(6):1189-94. PubMed ID: 15547736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
    Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between expression of Smac and Survivin and apoptosis of primary hepatocellular carcinoma.
    Bao ST; Gui SQ; Lin MS
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):580-3. PubMed ID: 17085346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological significance of survivin expression in patients with hepatocellular carcinoma.
    Chau GY; Lee AF; Tsay SH; Ke YR; Kao HL; Wong FH; Tsou AP; Chau YP
    Histopathology; 2007 Aug; 51(2):204-18. PubMed ID: 17559540
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter.
    Lim SO; Gu JM; Kim MS; Kim HS; Park YN; Park CK; Cho JW; Park YM; Jung G
    Gastroenterology; 2008 Dec; 135(6):2128-40, 2140.e1-8. PubMed ID: 18801366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S; Kanda M; Okamura Y; Nishikawa Y; Qiyong L; Fujii T; Sugimoto H; Takeda S; Nakao A
    Ann Surg Oncol; 2010 Mar; 17(3):923-32. PubMed ID: 19898900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.
    Ikeguchi M; Iwamoto A; Taniguchi K; Katano K; Hirooka Y
    J Exp Clin Cancer Res; 2005 Sep; 24(3):415-21. PubMed ID: 16270528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo expression patterns of survivin and its splicing variants in chronic liver disease and hepatocellular carcinoma.
    Takashima H; Nakajima T; Moriguchi M; Sekoguchi S; Nishikawa T; Watanabe T; Katagishi T; Kimura H; Minami M; Itoh Y; Kagawa K; Okanoue T
    Liver Int; 2005 Feb; 25(1):77-84. PubMed ID: 15698402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant methylation of the CHFR gene in advanced hepatocellular carcinoma.
    Sakai M; Hibi K; Kanazumi N; Nomoto S; Inoue S; Takeda S; Nakao A
    Hepatogastroenterology; 2005; 52(66):1854-7. PubMed ID: 16334792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoter hypermethylation of the p16 gene is associated with poor prognosis in recurrent early-stage hepatocellular carcinoma.
    Ko E; Kim Y; Kim SJ; Joh JW; Song S; Park CK; Park J; Kim DH
    Cancer Epidemiol Biomarkers Prev; 2008 Sep; 17(9):2260-7. PubMed ID: 18723830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypomethylated P4 promoter induces expression of the insulin-like growth factor-II gene in hepatocellular carcinoma in a Chinese population.
    Tang SH; Yang DH; Huang W; Zhou HK; Lu XH; Ye G
    Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4171-7. PubMed ID: 16857788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survivin expression and its relationship with apoptosis and prognosis in nasal and paranasal sinus carcinomas.
    Zhang Y; Huang D; Yu G
    Acta Otolaryngol; 2005 Dec; 125(12):1345-50. PubMed ID: 16303685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan.
    Hsu LS; Lee HC; Chau GY; Yin PH; Chi CW; Lui WY
    Oncol Rep; 2006 Feb; 15(2):507-11. PubMed ID: 16391877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.
    Yeo W; Wong N; Wong WL; Lai PB; Zhong S; Johnson PJ
    Liver Int; 2005 Apr; 25(2):266-72. PubMed ID: 15780049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promoter methylation of the secreted frizzled-related protein 1 gene SFRP1 is frequent in hepatocellular carcinoma.
    Shih YL; Shyu RY; Hsieh CB; Lai HC; Liu KY; Chu TY; Lin YW
    Cancer; 2006 Aug; 107(3):579-90. PubMed ID: 16795071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation.
    Zhang W; Zhou L; Ding SM; Xie HY; Xu X; Wu J; Chen QX; Zhang F; Wei BJ; Eldin AT; Zheng SS
    Oncol Rep; 2011 Apr; 25(4):1053-62. PubMed ID: 21271221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer.
    Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E
    Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re-expression of transcription factor ATF5 in hepatocellular carcinoma induces G2-M arrest.
    Gho JW; Ip WK; Chan KY; Law PT; Lai PB; Wong N
    Cancer Res; 2008 Aug; 68(16):6743-51. PubMed ID: 18701499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.